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The carnitine carrier from rat liver mitochondria has been extracted with Triton X-100 and partially purified by 
chromatography on hydroxyapatite and celite. During purification the activity of the carrier was monitored by functional 
reconstitution into liposomes. The purified fraction is 250-fold enriched with respect to the N-ethylmaleimide-sensitive 
carnitine/carnitine transport activity. The substrate specificity and the inhibitor sensitivity of carnitine transport in 
liposomes resemble closely those described for the transport of carnitine in mitochondria. 
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1. INTRODUCTION 
The inner mitochondrial  membrane contains a 
specific carrier system for the transport  of car- 
nit ine (for a review see [11). Under physiological 
condit ions this system catalyzes the exchange be- 
tween external acylcarnitine and matrix carnitine, 
which is an important  step in the mitochondrial  ox- 
~idation of fatty acids. The properties of the car- 
nit ine carrier have been extensively investigated in
intact mitochondria [2-7]. More recently, Noel et 
al. [8,9] have reconstituted the transport of car- 
nit ine in l iposomes using total mitochondrial  ex- 
tract. However, purif ication of the transport 
system has not yet been achieved. 
In this report we describe a partial purif ication 
of the carnit ine carrier from rat liver mitochon- 
dria. The carrier is about 250-fold enriched and, 
when reconstituted into phosphol ipid vesicles, 
closely resembles the properties of the carnitine 
transport  system as characterized in intact 
mitochondria.  
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2. MATERIALS  AND METHODS 
Hydroxyapatite (Bio-Gel HTP) was purchased from Bio- 
Rad, Celite 535 from Roth, Amberlite XAD-2 from Fluka, L- 
[3H]carnitine from Amersham, phospholipids (phosphatidyl- 
choline from fresh turkey egg yolk), cardiolipin, Pipes 
(1,4-piperazinediethanesulfonic acid), Triton X-100, L- 
carnitine, DL-octanoylcarnitine, N-octyl- and N-dodecyl-N,N- 
dimethyl-3-ammonio-l-propanesulfonate from Calbiochem. 
All other reagents were of analytical grade. 
Rat liver mitochondria prepared by standard procedures were 
solubilized in 2.5°?0 Triton X-100 (w/v)/50 mM NaC1/1 mM 
DTE/10 mM Pipes, pH 7.0 (16-18 mg protein/ml), and cen- 
trifuged at 100000 x g for 30 min at 0°C. 0.6 ml of the super- 
natant (extract) were applied to a dry hydroxyapatite (2 g) 
column and eluted with 1% Triton X-100/20 mM 
Na2SO4/1 mM DTE/10 mM Pipes, pH 7.0, at 0.05 ml/min. 
The first 0.5 ml of the eluate, supplemented with cardiolipin 
(2 mg), were applied to a dry celite (0.25 g) column and eluted 
with the same hydroxyapatite buffer plus cardiolipin 
(4 mg/ml). Protein eluates were reconstituted bythe amberlite 
method as described in [10,11], except that the reconstitution 
mixture consisted of 200/A of the hydroxyapatite or celite 
eluate or 50/LI of the extract, 15/zl cardiolipin (40 mg/ml), 
60/~1 of 10% Triton X-100, 80/zl liposomes (10% 
phospholipids), 20 mM carnitine, 50 mM NazHPO4, pH 7.0, in 
a final volume of 550/A. The external substrate was removed by 
chromatography of the liposomes on Sephadex G-75 pre- 
equilibrated with 20 mM NaCI/50 mM Na2HPO4. Transport 
measurements were performed by the inhibitor stop method 
[ 12] by adding 0.1 mM [3H]carnitine to the proteoliposomes at 
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time zero and using 2 mM N-ethylmaleimide as stopping 
reagent. In control samples, the inhibitor was added together 
with the labelled substrate. The external radioactivity was 
removed by applying 50,ul of the samples on Sephadex G-50 
columns (5.5 × 0.6 cm). The liposomes were eluted within 
1.1 ml sample using 50 mM NaC1. The eluted liposomes were 
collected in the scintillation mixture (maxifluor, Baker) and 
counted. The transport activity was calculated by subtracting 
the control from the experimental values. Polyacrylamide slab 
gel electrophoresis was performed in the presence of 0.1% SDS 
according to Laemmli [13]. Protein was determined by the 
Lowry method modified for the presence of Triton [14]. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and partial purification 
In order to isolate the carnitine carrier, the 
Triton X-100 extract of liver mitochondria was 
separated by various techniques and the different 
fractions were analyzed for carnitine transport ac- 
tivity and the polypeptide pattern in SDS-gel elec- 
trophoresis. An efficient purification was obtained 
by applying the crude extract of liver mitochondria 
to hydroxyapatite (table 1). The carnitine carrier 
passed through hydroxyapatite whereas most of 
the other proteins were retained under these condi- 
tions. Critical factors for optimal purification were 
found to be the rate of elution and the hydrox- 
yapatite/protein ratio. The activity of the carnitine 
carrier was retained by the column when the rate of 
elution was below 0.02 ml/min and the hydrox- 
yapatite/protein ratio (w/w) higher than 200. 
Under the conditions described in section 2, 
chromatography on hydroxyapatite increased the 
specific activity of the reconstituted carnitine/car- 
nitine exchange 94-fold. The total activity in the 
eluate after hydroxyapatite accounted for 79°70 of 
that applied to the column. 
For further purification, the hydroxyapatite 
pass-through ad to be supplemented with car- 
diolipin and subjected to chromatography on celite 
(table 1). By this purification step the specific ac- 
tivity of the reconstituted carnitine transport was 
further increased 2.7-fold. It should be stressed 
that in the absence of cardiolipin the carnitine car- 
rier was retained by celite. The entire purification 
procedure including addition of cardiolipin in- 
creased the specific activity of reconstituted car- 
nitine transport 252-fold as compared to that of 
the mitochondrial extract. Approx. 48°70 of the 
total transport activity was recovered with a pro- 
tein yield of 0.207o. The SDS-gel electrophoresis of 
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Table 1 
Purification of the carnitine carrier by chromatography on
hydroxyapatite and celite 
Protein Specific Total Purifica- 
(mg/ml) activity activity tion (fold) 
Triton X-100 mito- 
chondrial extract 9.4 2.5 23.5 - 
Hydroxyapatite 0.076 235 17.9 94 
Celite 0.018 630 11.3 252 
Conditions as described in section 2. The activity of the 
reconstituted carnitine/carnitine exchange is expressed as 
/zmol/10 min per g protein (specific activity) and/zmol/10 min 
(total activity) 
the final eluate showed 4-5 protein bands (fig. 1, 
lane D), the most prominent of which at Mr 30000 
and 35500 correspond to the ADP/ATP carrier 
and porin, respectively. The 35500 Da band was 
the only protein eluted from celite in the absence of 
cardiolipin (lane C) and it has been identified with 
porin both functionally and immunologically (not 
shown). 
3.2. Properties of the reconstituted carnitine 
carrier 
The substrate specificity of the partially purified 
carnitine carrier was investigated by changing the 
substrate ntrapped in the liposomes as well as by 
studying the effect of externally added substrates 
on the [3H]carnitine/carnitine exchange. The data 
illustrated in fig.2A show that [3H]carnitine x- 
changes not only with internal carnitine but also 
with DL-octanoylcarnitine. The uptake of labelled 
carnitine was negligible when the proteoliposomes 
were not loaded with carnitine, as found in 
mitochondria [5]. Virtually no uptake occurred 
without incorporation of the purified fraction into 
the liposomes or when the proteoliposomes con- 
tained substrates of other mitochondrial carriers 
like citrate, ADP, phosphate and oxoglutarate (not 
shown). Among the externally added substrates, 
DL-octanoylcarnitine strongly inhibited the car- 
nitine/carnitine exchange (fig.2B). In contrast, 
ADP, citrate, phosphate, oxoglutarate, malate and 
aspartate had very little effect (not shown). The in- 
hibitor sensitivity of the purified carnitine 
transport protein is shown in fig.2B. As in 
mitochondria [4,7], the reconstituted carnitine x- 
change was inhibited by mersalyl, N-octyl-N,N- 
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Fig.1. SDS-gel electrophoresis of fractions obtained uring the 
purification of the carnitine carrier. (M) Marker proteins 
(bovine serum albumin, carbonic anhydrase and cytochrome c); 
(A) mitochondrial extract; (B) hydroxyapatite eluate; (C) celite 
eluate without added cardiolipin; (D) celite eluate with added 
cardiolipin. 
d imethy l -3 -ammonio - l -p ropanesu l fonate  and N- 
dodecy l -N ,N-d imethy l -3 -ammonio -  1 -propanesul -  
fonate,  besides N-ethylmale imide used in the 
present paper  as stop inhibitor of  the carnit ine 
t ransport .  We have tested that the above men- 
t ioned sulfobetaines do not exert detergent effect 
at the concentrat ions used in this experiment.  In 
contrast ,  known inhibitors of  other mitochondr ia l  
carr iers (carboxyatractylos ide,  1 2,3-benzenetri-  
carboxylate,  buty lmalonate  and phthalonate)  had 
no signif icant effect. 
The t ime course of  the carni t ine/carni t ine ex- 
change, as reported in fig.2, can be analyzed 
kinetical ly [15]. By plott ing the logar i thm of  
the rat io carnit inemax/(carnit inemax-carnit inet)  
against  t ime, a straight line was obtained,  which 
demonstrates  that the reconst ituted carni t ine/car-  
nit ine exchange fol lows a f i rst-order kinetics, as 
found for other mitochondr ia l  carr ier-mediated 
t ransports  [16,17]. The f i rst-order ate constant,  k, 
was 0.04 min -1. 
In conclusion, it has been shown that a protein 
f ract ion with a 250-fold enriched specific t ransport  
activity contains the funct ional ly active carnit ine 
carrier.  The reconst i tuted protein exhibits the same 
substrate specif icity and inhibitor sensitivity of  the 
t ranspor t  system in mitochondr ia .  Since the purity 
o f  the reconst i tuted protein fract ion is still 
Fig.2. Substrate specificity and inhibitor sensitivity of the 
carnitine transport protein in reconstituted liposomes. (A) 
0.1 mM [3H]carnitine was added at time zero to 
proteoliposomes with 20 mM carnitine (o) or 40 mM DL- 
octanoylcarnitine ( i)  as internal substrate, or to 
proteoliposomes without internal substrate (A). (B) 
Proteoliposomes were loaded with 20 mM carnitine and the 
exchange was started with 0.1 mM external [3H]carnitine (o). 
The inhibitors 1.7 mM N-dodecyl-N,N-dimethyl-3-ammonio- 
1-propanesulfonate ( ), 5 mM DL-octanoylcarnitine (n), 
8 mM N.octyl-N,N-dimethyl-3-ammonio-l-propanesulfonate 
(x) were added simultaneously with [~H]carnitine. Mersalyl (•) 
was added 1 min before the labelled substrate at a 
concentration f 1 mM. 
unknown,  the specific activity of  carnit ine ex- 
change obtained in proteol iposomes cannot be cor- 
related quantitat ively to the original mitochondr ia l  
activity. However,  the rate of  reconst ituted car- 
n i t ine/carni t ine xchange is in the same order of  
magni tude as the values found for other 
reconst i tuted mitochondr ia l  metabol i te  carriers 
[18,19] and definitely lower than the rate of  the 
reconst i tuted phosphate carrier [20] which also has 
a higher specific activity in mitochondr ia .  
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